AAAAAA

   
Results: 1-9 |
Results: 9
Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptides
Authors: Lee, TV Kim, DK Peoples, GE Castilleja, A Murray, JL Gershenson, DM Ioannides, CG
Citation: Tv. Lee et al., Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptides, J INTERF CY, 20(4), 2000, pp. 391-401
Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals
Authors: Anderson, BW Peoples, GE Murray, JL Gillogly, MA Gershenson, DM Ioannides, CG
Citation: Bw. Anderson et al., Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals, CLIN CANC R, 6(11), 2000, pp. 4192-4200
Identification of activated tumor antigen-reactive CD8(+) cells in healthyindividuals
Authors: Lee, TV Anderson, BW Peoples, GE Castilleja, A Murray, JL Gershenson, DM Ioannides, CG
Citation: Tv. Lee et al., Identification of activated tumor antigen-reactive CD8(+) cells in healthyindividuals, ONCOL REP, 7(3), 2000, pp. 455-466
Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer
Authors: Miller, AR Cantor, SB Peoples, GE Pearlstone, DB Skibber, JM
Citation: Ar. Miller et al., Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer, DIS COL REC, 43(12), 2000, pp. 1695-1701
Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer - Reply
Authors: Miller, AR Cantor, SB Pearlstone, DB Peoples, GE Skibber, JM
Citation: Ar. Miller et al., Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer - Reply, DIS COL REC, 43(12), 2000, pp. 1702-1703
Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers
Authors: Peoples, GE Anderson, BW Lee, TV Murray, JL Kudelka, AP Wharton, JT Ioannides, CG
Citation: Ge. Peoples et al., Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers, CLIN CANC R, 5(12), 1999, pp. 4214-4223
Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer
Authors: Heaton, KM Peoples, GE Singletary, SE Feig, BW Ross, MI Ames, FC Buchholz, TA Strom, EA McNeese, MD Hunt, KK
Citation: Km. Heaton et al., Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer, ANN SURG O, 6(1), 1999, pp. 102-108
Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients
Authors: Kim, DK Lee, TV Castilleja, A Anderson, BW Peoples, GE Kudelka, AP Murray, JL Sittisomwong, T Wharton, JT Kim, JW Ioannides, CG
Citation: Dk. Kim et al., Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients, ANTICANC R, 19(4B), 1999, pp. 2907-2916
Ovarian cancer-associated lymphocyte recognition of folate binding proteinpeptides
Authors: Peoples, GE Anderson, BW Fisk, B Kudelka, AP Wharton, JT Ioannides, CG
Citation: Ge. Peoples et al., Ovarian cancer-associated lymphocyte recognition of folate binding proteinpeptides, ANN SURG O, 5(8), 1998, pp. 743-750
Risultati: 1-9 |